Pharmacists' Role in Opioid Safety: A Focus Group Investigation

Daniel M. Hartung, Jennifer Hall, Sarah N. Haverly, David Cameron, Lindsey Alley, Christi Hildebran, Nicole O'Kane, Deborah Cohen

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objective: The pharmacist's role and responsibilities in addressing the opioid epidemic have yet to be clearly defined, particularly from the patient's point of view. This qualitative study explores the pharmacist's role in promoting opioid safety from the perspective of pharmacists and patients. Design: Focus groups. Setting: Patient groups were held in person, and pharmacist groups were held online. Subjects: Oregon pharmacists (N = 19, Mage = 39.0 years, range = 26-57 years, 58% female) and patients (N = 18, Mage = 60.1 years, range = 30-77 years, 71% female) with current experience dispensing or receiving opioid medications. Methods: Pharmacists were asked about the challenges and opportunities for opioid safety monitoring and prescription dispensing. Patients were asked about their experiences accessing care, medications, and safety information. Focus group data were analyzed by a multidisciplinary team using an immersion-crystallization approach. Results: Pharmacists and patients agreed that pharmacists are responsible for medication safety. Pharmacists expressed discomfort filling potentially high-risk opioid prescriptions and noted barriers such as lack of clinical information and discomfort policing high-risk prescribing. Patients were concerned about pharmacists potentially overstepping their professional responsibilities by interfering with prescribers' clinical decisions. Conclusions: Feedback from both pharmacists and patient participants suggests that there is uncertainty in the degree to which pharmacists can and should confront the prescription opioid epidemic directly. Ambiguities in the pharmacist's role may be best clarified through structured training promoting enhanced between-party communication.

Original languageEnglish (US)
Pages (from-to)1799-1806
Number of pages8
JournalPain medicine (Malden, Mass.)
Volume19
Issue number9
DOIs
StatePublished - Sep 1 2018

Fingerprint

Focus Groups
Pharmacists
Opioid Analgesics
Safety
Prescriptions
Immersion
Crystallization
Uncertainty
Communication

ASJC Scopus subject areas

  • Clinical Neurology
  • Anesthesiology and Pain Medicine

Cite this

Hartung, D. M., Hall, J., Haverly, S. N., Cameron, D., Alley, L., Hildebran, C., ... Cohen, D. (2018). Pharmacists' Role in Opioid Safety: A Focus Group Investigation. Pain medicine (Malden, Mass.), 19(9), 1799-1806. https://doi.org/10.1093/pm/pnx139

Pharmacists' Role in Opioid Safety : A Focus Group Investigation. / Hartung, Daniel M.; Hall, Jennifer; Haverly, Sarah N.; Cameron, David; Alley, Lindsey; Hildebran, Christi; O'Kane, Nicole; Cohen, Deborah.

In: Pain medicine (Malden, Mass.), Vol. 19, No. 9, 01.09.2018, p. 1799-1806.

Research output: Contribution to journalArticle

Hartung, DM, Hall, J, Haverly, SN, Cameron, D, Alley, L, Hildebran, C, O'Kane, N & Cohen, D 2018, 'Pharmacists' Role in Opioid Safety: A Focus Group Investigation', Pain medicine (Malden, Mass.), vol. 19, no. 9, pp. 1799-1806. https://doi.org/10.1093/pm/pnx139
Hartung DM, Hall J, Haverly SN, Cameron D, Alley L, Hildebran C et al. Pharmacists' Role in Opioid Safety: A Focus Group Investigation. Pain medicine (Malden, Mass.). 2018 Sep 1;19(9):1799-1806. https://doi.org/10.1093/pm/pnx139
Hartung, Daniel M. ; Hall, Jennifer ; Haverly, Sarah N. ; Cameron, David ; Alley, Lindsey ; Hildebran, Christi ; O'Kane, Nicole ; Cohen, Deborah. / Pharmacists' Role in Opioid Safety : A Focus Group Investigation. In: Pain medicine (Malden, Mass.). 2018 ; Vol. 19, No. 9. pp. 1799-1806.
@article{a5e07d0edadb485698d539ba67b2f18e,
title = "Pharmacists' Role in Opioid Safety: A Focus Group Investigation",
abstract = "Objective: The pharmacist's role and responsibilities in addressing the opioid epidemic have yet to be clearly defined, particularly from the patient's point of view. This qualitative study explores the pharmacist's role in promoting opioid safety from the perspective of pharmacists and patients. Design: Focus groups. Setting: Patient groups were held in person, and pharmacist groups were held online. Subjects: Oregon pharmacists (N = 19, Mage = 39.0 years, range = 26-57 years, 58{\%} female) and patients (N = 18, Mage = 60.1 years, range = 30-77 years, 71{\%} female) with current experience dispensing or receiving opioid medications. Methods: Pharmacists were asked about the challenges and opportunities for opioid safety monitoring and prescription dispensing. Patients were asked about their experiences accessing care, medications, and safety information. Focus group data were analyzed by a multidisciplinary team using an immersion-crystallization approach. Results: Pharmacists and patients agreed that pharmacists are responsible for medication safety. Pharmacists expressed discomfort filling potentially high-risk opioid prescriptions and noted barriers such as lack of clinical information and discomfort policing high-risk prescribing. Patients were concerned about pharmacists potentially overstepping their professional responsibilities by interfering with prescribers' clinical decisions. Conclusions: Feedback from both pharmacists and patient participants suggests that there is uncertainty in the degree to which pharmacists can and should confront the prescription opioid epidemic directly. Ambiguities in the pharmacist's role may be best clarified through structured training promoting enhanced between-party communication.",
author = "Hartung, {Daniel M.} and Jennifer Hall and Haverly, {Sarah N.} and David Cameron and Lindsey Alley and Christi Hildebran and Nicole O'Kane and Deborah Cohen",
year = "2018",
month = "9",
day = "1",
doi = "10.1093/pm/pnx139",
language = "English (US)",
volume = "19",
pages = "1799--1806",
journal = "Pain Medicine",
issn = "1526-2375",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Pharmacists' Role in Opioid Safety

T2 - A Focus Group Investigation

AU - Hartung, Daniel M.

AU - Hall, Jennifer

AU - Haverly, Sarah N.

AU - Cameron, David

AU - Alley, Lindsey

AU - Hildebran, Christi

AU - O'Kane, Nicole

AU - Cohen, Deborah

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Objective: The pharmacist's role and responsibilities in addressing the opioid epidemic have yet to be clearly defined, particularly from the patient's point of view. This qualitative study explores the pharmacist's role in promoting opioid safety from the perspective of pharmacists and patients. Design: Focus groups. Setting: Patient groups were held in person, and pharmacist groups were held online. Subjects: Oregon pharmacists (N = 19, Mage = 39.0 years, range = 26-57 years, 58% female) and patients (N = 18, Mage = 60.1 years, range = 30-77 years, 71% female) with current experience dispensing or receiving opioid medications. Methods: Pharmacists were asked about the challenges and opportunities for opioid safety monitoring and prescription dispensing. Patients were asked about their experiences accessing care, medications, and safety information. Focus group data were analyzed by a multidisciplinary team using an immersion-crystallization approach. Results: Pharmacists and patients agreed that pharmacists are responsible for medication safety. Pharmacists expressed discomfort filling potentially high-risk opioid prescriptions and noted barriers such as lack of clinical information and discomfort policing high-risk prescribing. Patients were concerned about pharmacists potentially overstepping their professional responsibilities by interfering with prescribers' clinical decisions. Conclusions: Feedback from both pharmacists and patient participants suggests that there is uncertainty in the degree to which pharmacists can and should confront the prescription opioid epidemic directly. Ambiguities in the pharmacist's role may be best clarified through structured training promoting enhanced between-party communication.

AB - Objective: The pharmacist's role and responsibilities in addressing the opioid epidemic have yet to be clearly defined, particularly from the patient's point of view. This qualitative study explores the pharmacist's role in promoting opioid safety from the perspective of pharmacists and patients. Design: Focus groups. Setting: Patient groups were held in person, and pharmacist groups were held online. Subjects: Oregon pharmacists (N = 19, Mage = 39.0 years, range = 26-57 years, 58% female) and patients (N = 18, Mage = 60.1 years, range = 30-77 years, 71% female) with current experience dispensing or receiving opioid medications. Methods: Pharmacists were asked about the challenges and opportunities for opioid safety monitoring and prescription dispensing. Patients were asked about their experiences accessing care, medications, and safety information. Focus group data were analyzed by a multidisciplinary team using an immersion-crystallization approach. Results: Pharmacists and patients agreed that pharmacists are responsible for medication safety. Pharmacists expressed discomfort filling potentially high-risk opioid prescriptions and noted barriers such as lack of clinical information and discomfort policing high-risk prescribing. Patients were concerned about pharmacists potentially overstepping their professional responsibilities by interfering with prescribers' clinical decisions. Conclusions: Feedback from both pharmacists and patient participants suggests that there is uncertainty in the degree to which pharmacists can and should confront the prescription opioid epidemic directly. Ambiguities in the pharmacist's role may be best clarified through structured training promoting enhanced between-party communication.

UR - http://www.scopus.com/inward/record.url?scp=85052848969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052848969&partnerID=8YFLogxK

U2 - 10.1093/pm/pnx139

DO - 10.1093/pm/pnx139

M3 - Article

C2 - 29016883

AN - SCOPUS:85052848969

VL - 19

SP - 1799

EP - 1806

JO - Pain Medicine

JF - Pain Medicine

SN - 1526-2375

IS - 9

ER -